Open Labelled Active Controlled Randomised Evaluation of Vajra Guggulu in the Management of Diabetic Neuropathy - NI

Principal Parul Institute of Ayurved0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.Age- 40-70 years (both years inclusive).
•2.Gender- Both male and female.
•3.Known cases of Diabetes mellitus with symptoms of Diabetic Neuropathy.
•4.Patients with good to moderate glycemic control.
•5.Patients with MNSI Questionnaire score of =7 and MNSI Examination Score of =2.5.
•6.Patients showing altered Vibratory perception of sensory stimulus on the basis of Bio-thesiometer.

•Patients suffering from any of the following diseases:
•1.Rheumatic disease.
•2.K/C/O Vitamin deficiency.
•3.Alcoholism and any other drug abuse.
•4.K/C/O Paraneoplastic disorder and any other SOL causing nerve dysfunction.
•5.K/C/O Cerebral vascular disease.
•6.K/C/O Parkinsonism and any other nerve degenerative disorders.
•7.K/C/O Leprosy, HIV-AIDS, STDs, and other immune-compromised conditions.
•8.Patients with acute complications of Diabetes mellitus.
•9.K/C/O uncontrolled Hypertension.
•10.Patients with known allergy to any drug ingredients of study medicine in trial group and control group.

发起方

Principal Parul Institute of Ayurved